Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05891873

Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations

Intensive and critical care in the intensive care unit (ICU) is often associated with ICU delirium and post-ICU dementia, regardless of the nature of the primary disease or insult. Optimal practical management of ICU delirium including its screening, prevention, and treatment, is an integral part of the current recommendations for optimal ICU care, but there are large gaps in the knowledge about the optimal and most effective prevention and treatment of this complication. Information on the actual implementation of these recommendations in the Czech Republic is lacking. The diagnosis of delirium is particularly challenging in neurointensive care patients (due to overlap with symptoms of primary brain lesions) and in a paediatric population. A complementary multicentre observational 4-year follow-up study, performed in an adult neurointensive/critical care stroke cohort and in a paediatric intensive/critical care cohort in centres following currently recommended preventive measures (Delusion-deep-cz) will investigate the incidence of ICU delirium and post-ICU dementia and their modifiable and non-modifiable predisposing and precipitating risk factors. Objectives are to determine the optimal methods for diagnostic screening of these complications and for the differential diagnosis of conditions mimicking delirium (non-convulsive epileptic state) or symptoms hindering its diagnosis (aphasia), and to study the association between sleep disturbances and ICU delirium to verify the role of sleep in the pathophysiology of delirium.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Brno University Hospital

Brno, 62500, Czechia

Location status: Recruiting

Location contact

Josef Bednařík, prof. MD, CSc.

CONTACT

[email protected]

532231481

About this study

Design

  • Multicentre observational follow-up cohort study with 2 different cohorts and a minimum follow-up period of 6 months.

Recruitment (groups)

  • Neurointensive/neurocritical group (N-ICU): patients with acute ischaemic or haemorrhagic stroke admitted to the Stroke Unit or ICU of the Department of Neurology, University Hospital Brno (NK-UHB).
  • Paediatric intensive/critical group (P-ICU): children aged 6-18 years, admitted to the Paediatric ICU - Department of Paediatric Anaesthesiology and Intensive Care (KDAR-UHB) with a stay of at least 24 hours (including postoperative care).

General working hypotheses

  • Current recommendations for the practical management (PADIS) and prevention of delirium lead to a decrease in the incidence of ICU-delirium and post-ICU dementia and may also change the spectrum of significant risk factors.
  • In the Czech Republic, both general knowledge and practical implementation of these recommendations may be low.
  • Currently recommended screening instruments for ICU-delirium are valid and reliable in both adult and paediatric cohorts of (neuro)intensive/critical patients and can replace the expert assessment using DSM-IV or V criteria (The Diagnostic and Statistical Manual of Mental Illnesses).
  • Non-convulsive status epilepticus (NCSE) may mimic ICU-delirium and a routine EEG exam in patients meeting the criteria for ICU delirium may be helpful.
  • Aphasia may complicate the diagnosis of delirium and may prevent the use of the current screening tools for delirium in neurointensive care patients.
  • Sleep disturbances in ICU patients are often associated with the development of ICU delirium and evaluating the time course of these conditions may reveal their possible causal relationship.

Outcomes Primary outcomes

  • Development of ICU delirium Secondary outcomes
  • Length of stay in ICU
  • Case-fatality risk
  • Post-ICU dementia (BDS, Blessed dementia scale)
  • Degree of functional dependency (Barthel index)

Objectives

  • To review the incidence and significant modifiable and non-modifiable predisposing and precipitating risk factors for ICU delirium and post-ICU dementia in general and neuro-intensive/critical care in adult and paediatric populations treated in health care facilities according to current recommendations for prevention of these complications (ABCDEF bundle).
  • To verify optimal methods for diagnostic screening of ICU delirium: CAM-ICU (The confusion assessment method for the ICU), 4AT (Rapid clinical test for delirium detection - 4AT) and ICDSC (Intensive care delirium screening checklist) in adult populations and pCAM-ICU (paediatric confusion assessment method for the ICU), psCAM-ICU (pre-school confusion assessment method for the ICU) and CAPD (Cornell Assessment of Pediatric Delirium) in paediatric populations to screen for delirium.
  • To verify optimal methods for the differential diagnosis of conditions that mimic or complicate the diagnosis of ICU delirium: NCSE, aphasia,
  • To investigate associations between sleep disturbances and ICU-delirium to confirm their role in the pathophysiology of delirium.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Neurointensive/neurocritical group (N-ICU): patients with acute ischaemic or haemorrhagic stroke admitted to the Stroke Unit or ICU of the Department of Neurology, University Hospital Brno (NK-UHB).
  • Paediatric intensive/critical group (P-ICU): children aged 6-18 years, admitted to the Paediatric ICU - Department of Paediatric Anaesthesiology and Intensive Care (KDAR-UHB) with a stay of at least 24 hours (including postoperative care).

Exclusion criteria

  • (N-ICU) severe trauma with short life expectancy (days)
  • duration of the ICU stay shorter than 24 hours

Treatment and study plan

CAM-ICU

Diagnostic Test

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

ICDSC

Diagnostic Test

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

4AT

Diagnostic Test

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

p(s)CAM-ICU

Diagnostic Test

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

CAPD

Diagnostic Test

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

MASTcz (The Mississippi Aphasia Screening Test)

Diagnostic Test

People with aphasia will be examined by a skilled speech therapist.

EEG

Diagnostic Test

Patients with positive delirium will undergo EEG examination. 10-min native EEG.

Primary outcomes

  1. Number of participants who develop ICU delirium

    Time frame: up to 14 days after admission

    assessed by experienced neuro-intensivist

Secondary outcomes

  1. Length of stay in ICU

    Time frame: up to 10 weeks

  2. Mortality

    Time frame: 6 months

  3. Number of participants and severity of post-ICU dementia, cognitive impairment(Blessed dementia scale, BDS)

    Time frame: 6 months

  4. Degree of functional dependency (Barthel index)

    Time frame: up to 10 weeks and after 6 months

    the higher score, the worse result meaning cognitive impairment and non-independence

Study contacts

Contact information is provided by the study sponsor or research team.

Josef Bednařík, prof. MD, CSc.

CONTACT

[email protected]

532231481

Lucia Bakošová, MD

CONTACT

[email protected]

532232503

Sponsors and collaborators

Lead sponsor

Masaryk University

Other

Collaborators

  • Brno University Hospital
  • University Hospital, Motol

Registry information

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Jun 7, 2023
Registry last updated
Oct 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.